Big Tech & Digital Health

Amazon Puts Amwell Co-Founder in Charge of Healthcare Unit

By Intent.Health Team May 28, 2026
Intent Health AI Data Flow

What’s happening

Amazon appointed an Amwell co-founder to lead its healthcare division after a longtime executive departed.

The appointment signals Amazon’s continued push into:

What’s changing / Business impact

This organizational realignment introduces new tactical shifts for tech-driven care:

Why this matters

Amazon has spent years trying to establish a beachhead in healthcare but has faced persistent organizational challenges successfully scaling its healthcare business operations.

This aggressive executive hire shows that big tech still views healthcare as a massive, non-negotiable long-term commercial opportunity, proving that leadership changes may signal major strategic restructuring.
Pharma & R&D

Bristol Myers Drug Delays Progression of Hard-to-Treat Multiple Myeloma

By Intent.Health Team May 29, 2026
Intent Health AI Data Flow

What’s happening

Bristol Myers Squibb reported that one of its experimental treatments delayed disease progression in patients with difficult-to-treat multiple myeloma, a type of blood cancer.

The results were presented as a positive step for patients who have exhausted many existing treatment options.

What’s changing / Business impact

Positive trial results strengthen Bristol Myers' cancer pipeline and support future regulatory submissions.

Why this matters

Patients with advanced multiple myeloma often have limited options after existing treatments stop working.